Isolated splenic high-grade serous carcinoma: A case report
- PMID: 34258358
- PMCID: PMC8253960
- DOI: 10.1016/j.gore.2021.100818
Isolated splenic high-grade serous carcinoma: A case report
Abstract
We present a unique case of high-grade serous carcinoma isolated to the spleen at the time of diagnosis, without any tumor present in the ovary, fallopian tubes, omentum or uterus, which was pathologically consistent with metastatic Mullerian carcinoma. Tumor sequencing with the MSK-IMPACT (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets) multigene tumor panel test was performed, which revealed somatic mutations in PALB2 and in ARID1, as well as a TP53 hotspot mutation.
Keywords: ARID1 somatic mutation; High-grade serous carcinoma; PALB2 mutation; Pluripotent spleen cell; Splenic Mullerian carcinoma; TP53 hotspot mutation.
© 2021 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Compérat, E., MD, Bardier-Dupas, A., MD, Camparo, P., MD, Capron, F., MD, and Charlotte, F., MD. (2007). Splenic Metastases: Clinicopathologic Presentation, Differential Diagnosis, and Pathogenesis. Archives of Pathology & Laboratory Medicine,131(6), 965-969. Retrieved November 28, 2020, from https://meridian.allenpress.com/aplm/article/131/6/965/62344/Splenic-Met.... - PubMed
-
- Dawoud, E., MD, PhD, Jansen, M., MD, FRCPath, and Al Shurbagy, D., MD, PhD., 2013. Solitary Splenic Metastasis from Ovarian Serous Adenocarcinoma: A Case Report. Austral-Asian Journal of Cancer,12(3), 175-180. Retrieved November 28, 2020, from http://www.australasiancancer.org/journal-article-view/solitary-splenic-....
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous